Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
Yara‐Natalie Abo, Euzebiusz Jamrozik, James McCarthy, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. e533-e546
Open Access | Times Cited: 17

Showing 17 citing articles:

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
Marco Cavaleri, David C. Kaslow, Eric Boateng, et al.
Biologicals (2024) Vol. 85, pp. 101745-101745
Open Access | Times Cited: 5
Rationale and Ethical Assessment of an Oropharyngeal Gonorrhoea Controlled Human Infection Model
Eloise Williams, Jane S. Hocking, Christopher K. Fairley, et al.
The Journal of Infectious Diseases (2025)
Closed Access
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics
Dain Lee, Anjalika Nande, Thayer L. Anderson, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 223
Open Access
homeRNA self-blood collection enables high-frequency temporal profiling of presymptomatic host immune kinetics to respiratory viral infection: a prospective cohort study
Fang Yun Lim, Hannah G. Lea, Ashley M. Dostie, et al.
EBioMedicine (2025) Vol. 112, pp. 105531-105531
Closed Access
Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?
Stephen Muhi, Simone Schmidt, Julia L. Marshall, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 2, pp. e0012593-e0012593
Open Access
Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men
Clair L. Firth, Katherine R. W. Emary, Andrew B. Stuart, et al.
Vaccine (2025) Vol. 54, pp. 127013-127013
Open Access
Reverse development of vaccines against antimicrobial-resistant pathogens
F. Bagnoli, Ilaria Galgani, V. Kumaran Vadivelu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report
Shobana Balasingam, Keertan Dheda, Sarah M. Fortune, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. e457-e464
Open Access | Times Cited: 2
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.
Stephen Muhi, Julia L. Marshall, D. O’Brien, et al.
Wellcome Open Research (2024) Vol. 9, pp. 488-488
Open Access | Times Cited: 1
Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses
Xiangchuan He, Tianxiang Zhang, Shitong Huan, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1573-1573
Open Access | Times Cited: 3
homeRNA self-blood collection enables high-frequency temporal profiling of presymptomatic host immune kinetics to respiratory viral infection: a prospective cohort study
Fang Yun Lim, Hannah G. Lea, Ashley M. Dostie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Streptococcus pyogenespharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections
Joshua Osowicki, Hannah R. Frost, Kristy Azzopardi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.
Stephen Muhi, Julia L. Marshall, D. O’Brien, et al.
Wellcome Open Research (2024) Vol. 9, pp. 488-488
Open Access
Ethics & utility of controlled human infection studies (CHIS) in low- & middle-income countries
Jake D Eberts, Nir Eyal, Sayantan Banerjee
The Indian Journal of Medical Research (2024) Vol. 160, pp. 262-266
Open Access
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections
Joshua Osowicki, Hannah R. Frost, Kristy Azzopardi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Controlled human infection trials: Legitimacy and conditions of implementation in France
Anne-Laure Morin, Emmanuelle Blanc, Armelle Phalipon, et al.
Therapies (2023) Vol. 79, Iss. 1, pp. 35-45
Closed Access
Essais d’infection contrôlée chez la personne humaine : légitimité et conditions de réalisation en France
Anne-Laure Morin, E. Blanc, Armelle Phalipon, et al.
Therapies (2023) Vol. 79, Iss. 1, pp. 23-33
Closed Access
Page 1

Scroll to top